Zielsetzung des Webinars:

Dieses Seminar richtet sich an Transfusionsmediziner, Transfusionslaborteams und Transfusionsberater, die die Bedürfnisse dieser speziellen Patientengruppe -den Neugeborenen- besser verstehen möchten.

Referentin: Martha Sola-Visner. MD.

Objetivos del seminario web:

Este seminario está dirigido a profesionales de transfusión, equipos de laboratorio de transfusión y consultores de transfusión con ánimo de comprender mejor las necesidades de este grupo especial de pacientes, los recién nacidos.

Oradora: Martha Sola-Visner. MD.

Ziele des Kurses:

• Nomenklatur
• HLAi & UKLKSS
• Organzuteilung
• Post-Transplantation

Referent: Miriam Manook, MBChB, MRCS (Ed), PhD

Objetivos del curso:

• Nomenclatura
• HLAi y UKLKSS
• Asignación
• Post-trasplante

Oradora: Miriam Manook, MBChB, MRCS (Ed), PhD

Webinar-Ziele:

• Auswirkung von HLA-Klasse-I-Signalpeptid-Variationen auf die HLA-E-Expression

Vortragende: Dr. Mary Carrington, Center for Cancer Research, Bethesda, ML 

Objetivos del seminario web:

• Efecto de la variación del péptido señal HLA Clase I en la expresión HLA-E 

Oradora: Dra. Mary Carrington, Centro de Investigación del Cáncer, Bethesda, ML

Webinar-Ziele:
• Normale und abnormale Ergebnisse des Gerinnungslabors definieren.
• Korrelation der Laborergebnisse mit häufigen klinischen Anzeichen und Symptomen des Patienten.
• Normale und abnormale Thrombozyten-Laborergebnisse unterscheiden.
• Anwendung von Gerinnungs- und Hämatologieergebnissen in Fallstudienbeispielen mit Fokus auf die Bereitstellung einer geeigneten Transfusion von Blutprodukten oder medizinischen Maßnahmen.

Vortragende: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Objetivos del seminario web:

• Definir resultados de laboratorio de coagulación normales y anormales.
• Correlacionar resultados de laboratorio con signos y síntomas clínicos comunes en el paciente.
• Discriminar resultados de laboratorio de plaquetas normales y anormales.
• Aplicar resultados de coagulación y hematología en estudios de casos centrándose en la provisión de transfusión de hemoderivados o intervención médica.

Oradora: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar-Ziele:

• Arbeitslisten-Management
• Ergebnis-Management
• Bericht-Management
• Panel ID | Module
• Archivierung

Vortragende: Gianni Giuffrè

Objetivos del seminario web:

• Gestión de listas de trabajo
• Gestión de resultados
• Gestión de informes
• Panel de identificación | Módulo
• Gestión de archivos

Oradora: Gianni Giuffrè

Objetivos del seminario web:

•  el desarrollo de la inmunohematología hasta los avances tecnológicos e investigació
• "genómica" y descubrimiento continuo de grupos sanguíneos

Oradora: Dr. Lilian Castilho

Webinar Objectives:

•  Learn more about PIRCHE
• How PIRCHE can help you see beyond limits of transplant diagnostics.

Speaker: Massimo Mangiola, Ph.D., A(ACHI)

Webinar Objecties:

• Understand the Clinical relevance of NK (natural killer) cells Immunogenetics

Speaker: Dr. Rajalingam Raja, UCSF, USA

Webinar Objectives:

• Worklist Management
• Results Management
• Report Management
• Panel ID | Module
• Archive Management

Speaker:  Gianni Giuffrè

Webinar Objective:

• Effect of HLA Class I Signal Peptide variation on HLA-E Expression 

Speaker: Dr. Mary Carrington, Center for Cancer Research, Bethesda, ML

Webinar Objectives:

• Nomenclature
• HLAi & UKLKSS
• Allocation
• Post-transplant

Speaker: Miriam Manook, MBChB, MRCS (Ed), PhD

Webinar Objectives:

This seminar is aimed at Transfusion Practitioners, Transfusion Laboratory Teams and Transfusion Consultants keen to better understand the needs of this special patient group, neonates.

Speaker: Martha Sola-Visner. MD.

Webinar Objectives:
• Organize and categorize transfusion complications given the reported signs and symptoms.
• Discover how laboratory findings correlate with the clinical signs and symptoms of transfusion complications.
• Compare and contrast acute and delayed transfusion reactions.
• Apply how to define the adverse complications of transfusion in example case studies.

Speaker: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar Objectives:
• Distinguish immune response into the action of T Cells and B Cells.
• Recognize the role of immunoglobulins and cells involved in primary and secondary immune response.
• Outline function and process of complement activation in transfusion medicine.
• Demonstrate genetic concepts of blood groups exploring pedigree analysis and population genetics.

Speaker: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar Objectives:
• Identify the common blood groups by genetic background, antigen, antibody and clinical significance.
• Discriminate uncommon blood groups by genetic background, antigen, antibody and clinical significance.
• Give examples of unique characteristics of blood groups and how they relate to the clinical outcomes in patients.
• Apply the knowledge of blood groups to provide the most appropriate blood products for transfusion.

Speaker: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar Objectives:
• Appraise the value of common serologic blood bank methods for the resolution
of serologic blood bank challenges.
• Categorize the methods and tools for atypical serum/plasma challenges compared to red cells challenges.
• Define a systematic approach for ABO discrepancies and atypical antibody detection findings.
• Employ serologic methods in case study examples to demonstrate efficient application.

Speaker:  Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar Objectives:
• Define normal and abnormal coagulation lab findings.
• Correlate laboratory results with common clinical signs and symptoms in the patient.
• Discriminate normal and abnormal platelet laboratory results.
• Apply coagulation and hematology results in case study examples focusing on the provision of appropriate
transfusion of blood products or medical intervention.

Speaker: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar Objectives:
• Explain detection and identification of red cell alloantibodies.
• Explore problem solving techniques including evaluation of the patient’s clinical and transfusion history, autocontrol, DAT and red cell phenotype.
• Define appropriate testing methods for IgM compared to IgG reactive antibodies.
• Apply antibody identification practices in case studies

Speaker: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar Objectives:

• HLA-DQ Antibodies in Solid Organ Transplantation

Speakers: Anat Roitberg-Tambur, DMD, PhD

Objetivos do seminário web:

• validação e conduta nas transfusões de plaquetas
• Crossmatching plaquetário
• Refratariedade Plaquetária.

Speakers: Ana Paula Rocha Diniz Zanelli; Cristina Altobeli; Juliana Pires Marafon Franz

Objetivos do seminário web:

• Reagentes Especiais em Imunohematologia: como usar e qual a importância na resolução de casos clínicos complexos
• A importância da detecção sorológica para direcionar a investigação molecular
• Tipagem molecular dos genes de grupos sanguíneos no auxílio diagnostico.

Speakers: Regina Cardoso; Tatiane de Paula Vendrame; Carine Arnoni, Tamires Delfino dos Santos, Lilian Castilho, PhD

Webinar Objectives:

•  Advances in treatments for patients with Sickle Cell Disease
•  National Haemoglobinopathy Registry

Speakers: Noemi Roy, Farrukh Shah

Webinar Objectives: 

• Immucor is committed to supporting the testing you perform by offering a complete and convenient line of competency testing products – from basic to advanced. Click 'LAUNCH COURSE' below to submit results for Self-check II Competency Kit.

Webinar Objectives: 

• Immucor is committed to supporting the testing you perform by offering a complete and convenient line of competency testing products – from basic to advanced.  Click 'LAUNCH COURSE' below to submit results for RiSE Competency Kit.

Webinar Objectives: 

• Immucor is committed to supporting the testing you perform by offering a complete and convenient line of competency testing products – from basic to advanced.  Click 'LAUNCH COURSE' below to submit results for Gamma® Tech-Chek Competency Kit.

Webinar Objectives: 

• The Eurotransplant Acceptable Mismatch Program
• How HLA epitope knowledge may benefit highly sensitized patients
• HLA-specific memory B cells: possible use for delisting and desensitization strategies
• Highly sensitized patients are disadvantaged by the presence of denatured HLA in Luminex HLA single antigen testing
• How implementing two SAB vendors can help patients

Speakers: Annette Jackson, Sebastiaan Heidt, Suzanne Bezstarosti, Gonca Karahan, Richard Battle, Alin Girnita 

Webinar Objectives: 

• The Genome Canada Consortium on Precision Medicine in Renal Transplantation
• The Evolution and Revolution in NGS
• Getting the basic building blocks rights- The impact of NGS based HLA typing on our clinical practice
• Definition of immunogenic and non-immunogenic HLA epitopes
• Updates from the HLA- DQ antibody component of the International Histocompatibility Workshop

Speakers: Paul Keown, Karen Sherwood, Sujatha Krisnakumar, Dolly Rose, Cynthia Kramer, Anat Tambur

Webinar Objectives: 

• What's in your toolbox? Experiences with LIFECODES ID assays
• What's in your toolbox? Experiences with LIFECODES LSA and C3d assays
• Non-HLA: A voyage into the unknown
• Clinical Relevance of Non-HLA Antibody Burden in Kidney Transplantation
• Non-HLA antibody panel: from bench to bedside

Speakers: Mike Gautreaux, Brett Loehmann, Bryan Ray, Alek Senev, Carrie Butler

Webinar Objectives:

• Blood component usage in the pre hospital setting
• The use of O positive red cells in the pre hospital setting

Speaker: Dr. James Raitt MBChB, FRCEM, FIMC, Kerry Dowling

Webinar Objectives: 

• Hematopoietic stem cell transplantation from unrelated donors in Germany
• Structures, Figures, Matching Guidelines, and Outcomes

Speaker: Dr. Joannis Mytilineos

Webinar Objectives: 

• HLA Matching Paradigms in Allogeneic HSCT

Speaker: Dr. Meenakshi Singh, Advanced center for Treatment, Research and Education in Cancer, Navi Mumbai, India

Webinar Objectives: 

• RhD Case Studies: Interpretation and Patient Risks in Transfusions
• Management of platelet alloimmunization on the Maternity Laboratory
• The challenging effects of monoclonal antibody therapies on the Transfusion Laboratory

Speakers: Dr Lilian Castilho, PhD, Dr Rachel Petermann, MD, PhD, Julie Staves Manager, Transfusion Laboratory

Webinar Objectives: 

• A breakthrough in ABO isoagglutinin titration automation: reason to believe & its benefits

Speakers: Dr. Soma Agrawal

Webinar Objectives:

• Overview of single antigen analysis technology
• Walk through of an interactive case study

Speakers: K. Kelly Cousins, Jean L. Heneghan

Webinar Objectives: 

• Methods to obtain access to CCP
• NYC & the Covid-19 Pandemic
• CUIMC CCP Clinical Trials
• Impacts on Transfusion Service operations

Speakers: Joseph (Yossi) Schwarts

Webinar Objectives:

• Advantages of Multi-Assay Analysis: Resolving Discrepancies between Solid Phase Immunoassays
• Non-HLA antibody panel discovery, development, and validation: From bench to bedside
• Redesigning HLA Compatibility: Does it work and are we ready?

Speaker: Julie Houp, MS CHS  Carrie L. Butler, Ph.D.  Massimo Mangiola, Ph.D. D(ACHI)

Webinar Objectives: 

• Overview of single antigen analysis technology
• Walk through of an interactive case study

Speakers: K. Kelly Cousins, Jean L. Heneghan

Webinar Objectives: 

• Overview of single antigen analysis technology
• Walk through of an interactive case study

Speakers: K. Kelly Cousins, Jean L. Heneghan

Webinar Objectives: 

• Transplanting sensitized candidates: new options for overcoming DSA barriers

Speaker: Annette Jackson

Webinar Objectives: 

• Diagnosis of antibody-meditated rejection in 2021: antibodies, biopsies, and molecules

Speaker: Michael Mengel

Webinar Objectives: 

• Lab week Case Studies with Lifecodes LSA

Speaker: Dave Pinelli 

Webinar Objectives:

• Describe the relationship between Ren Blood cell antigens and their corresponding antibodies
• Learn about genes, antigens, and antibodies and how they are arranged in each system

Speaker: N/A

Webinar Objectives: 

• Discuss antibody development as part of the immune system
• Compare and contrast IgM and IgG class antibodies
• Examine reactivity of IgM and IgG class antibodies in common antibody detection methodologies
• Review publications on clinical significance of IgM and IgG class antibodies

Speaker: Tricia Sanders

Webinar Objectives: 

• Review Chronic Transfusion Therapy (CTT) for Sickle Cell Anemia (SCA)
• Present a prospective study of RBC genotyping of SCA patients and transfused units during CTT
• Clinical applications

Speaker: Marianne E. McPherson Yee, MD

Webinar Objectives: 

• Geneotyping to resolve e-like Antibodies

Speaker: Dr. Shaun Lawicki, MBBS